Chumpradit S, Kung M P, Billings J J, Kung H F
Department of Radiology, University of Pennsylvania, Philadelphia 19104.
J Med Chem. 1991 Mar;34(3):877-83. doi: 10.1021/jm00107a002.
The synthesis and resolution of (+-)-7-chloro-8-hydroxy-1-(3'-iodophenyl)-3-methyl-2,3,4,5-tetrahydro-1 H-3- benzazepine, (+/-)-TISCH (8) has been achieved by resolution of intermediate 4, the O-methoxyl, 3'-bromo derivative, as the diastereomeric camphor sulfonate salt. The final products, R-(+)-8 and S-(-)-8, were prepared by treatment of R-(+)- or S-(-)-7, the 3'-tributyltin intermediates, with iodine in chloroform, followed by O-demethylation. By using HPLC with a chiral column, the optical purity (greater than 99%) of the intermediates and the final compounds was determined. Radioiodination was achieved by an iodo-destannylation reaction with sodium [125I]iodide and hydrogen peroxide. As expected, the R-(+)-[125I]-8 (the active isomer) displayed high affinity and selectivity to the CNS D-1 receptor in rat striatum tissue preparation (Kd = 0.205 nM). The rank order of potency was as follows: SCH-23390 (1a) greater than (+/-)-8 greater than (+)-butaclamol greater than spiperone, WB4101 greater than dopamine, 5-HT. After an iv injection, the R-(+)-[125I]-8 penetrated the blood-brain barrier with ease and displayed specific regional distribution corresponding to the D-1 receptor density, while the S-(-)-[125I]-8 showed no specific uptake. The data suggest that the ligand may be useful as a pharmacological tool for characterizing the D-1 dopamine receptor. When labeled with I-123, this ligand is a potential agent for in vivo imaging of CNS D-1 dopamine receptor.
通过拆分中间体4(O-甲氧基-3'-溴衍生物)的非对映体樟脑磺酸盐,实现了(±)-7-氯-8-羟基-1-(3'-碘苯基)-3-甲基-2,3,4,5-四氢-1H-3-苯并氮杂卓((±)-TISCH,8)的合成与拆分。通过用氯仿中的碘处理R-(+)-或S-(-)-7(3'-三丁基锡中间体),然后进行O-去甲基化,制备了最终产物R-(+)-8和S-(-)-8。通过使用手性柱的高效液相色谱法,测定了中间体和最终化合物的光学纯度(大于99%)。通过与碘化钠[125I]和过氧化氢的碘代脱锡反应实现放射性碘化。正如预期的那样,R-(+)-[125I]-8(活性异构体)在大鼠纹状体组织制备中对中枢神经系统D-1受体表现出高亲和力和选择性(Kd = 0.205 nM)。效价顺序如下:SCH-23390(1a)大于(±)-8大于(+)-布他拉莫大于螺哌隆,WB4101大于多巴胺,5-羟色胺。静脉注射后,R-(+)-[125I]-8轻松穿透血脑屏障,并表现出与D-1受体密度相对应的特定区域分布,而S-(-)-[125I]-8没有显示出特异性摄取。数据表明该配体可能作为表征D-1多巴胺受体的药理学工具有用。当用I-123标记时,该配体是用于中枢神经系统D-1多巴胺受体体内成像的潜在试剂。